Abstract
A Phase II Study of 5-Azacytidine (AZA) and Venetoclax As Maintenance Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have